Patents by Inventor J. Oliver Dolly

J. Oliver Dolly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACTIVATABLE RECOMBINANT NEUROTOXINS
    Publication number: 20080311622
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: July 30, 2008
    Publication date: December 18, 2008
    Inventors: J. OLIVER DOLLY, Yan Li, Kuo Chion Chan
  • Activatable Clostridial Toxins
    Publication number: 20080221012
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: August 27, 2007
    Publication date: September 11, 2008
    Applicant: Allergan, Inc.
    Inventors: Lance E. Steward, Joseph Francis, Ester Fernandez-Salas, Marcella A. Gilmore, Shengwen Li, J. Oliver Dolly, Kei Roger Aoki
  • Activatable recombinant neurotoxins
    Patent number: 7422877
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: December 13, 2006
    Date of Patent: September 9, 2008
    Assignee: Allergan, Inc.
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • Activatable recombinant neurotoxins
    Patent number: 7419676
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Grant
    Filed: January 5, 2006
    Date of Patent: September 2, 2008
    Assignee: Allergan, Inc.
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • ACTIVATABLE RECOMBINANT NEUROTOXINS
    Publication number: 20080182294
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: October 29, 2007
    Publication date: July 31, 2008
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan
  • Activatable Clostridial Toxins
    Publication number: 20080161226
    Abstract: Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
    Type: Application
    Filed: August 27, 2007
    Publication date: July 3, 2008
    Applicant: Allergan, Inc.
    Inventors: Lance E. Steward, Joseph Francis, Ester Fernandez-Salas, Marcella A. Gilmore, Shengwen Li, J. Oliver Dolly, Kei Roger Aoki
  • Activatable recombinant neurotoxins
    Patent number: 7132259
    Abstract: The invention provides, in part, compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also provides, in part, nucleic acid molecules encoding such polypeptides, and methods of making such polypeptides and nucleic acid molecules.
    Type: Grant
    Filed: August 25, 2000
    Date of Patent: November 7, 2006
    Assignee: Allergan, Inc.
    Inventors: J. Oliver Dolly, Yan Li, Kuo Chion Chan